Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.

Blood
George MulliganMatthew Schu

Abstract

Various translocations and mutations have been identified in myeloma, and certain aberrations, such as t(4;14) and del17, are linked with disease prognosis. To investigate mutational prevalence in myeloma and associations between mutations and patient outcomes, we tested a panel of 41 known oncogenes and tumor suppressor genes in tumor samples from 133 relapsed myeloma patients participating in phase 2 or 3 clinical trials of bortezomib. DNA mutations were identified in 14 genes. BRAF as well as RAS genes were mutated in a large proportion of cases (45.9%) and these mutations were mutually exclusive. New recurrent mutations were also identified, including in the PDGFRA and JAK3 genes. NRAS mutations were associated with a significantly lower response rate to single-agent bortezomib (7% vs 53% in patients with mutant vs wild-type NRAS, P = .00116, Bonferroni-corrected P = .016), as well as shorter time to progression in bortezomib-treated patients (P = .0058, Bonferroni-corrected P = .012). However, NRAS mutation did not impact outcome in patients treated with high-dose dexamethasone. KRAS mutation did not reduce sensitivity to bortezomib or dexamethasone. These findings identify a significant clinical impact of NRAS mutation in...Continue Reading

References

Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Oct 6, 2004·British Journal of Haematology·S JagannathK C Anderson
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P Leif Bergsagel, W Michael Kuehl
Dec 3, 2005·Leukemia & Lymphoma·Manoela M OrtegaCarmen S P Lima
Sep 11, 2008·Pharmacogenomics·Amy Cullinan, Charles Cantor
Nov 20, 2009·PloS One·Laura E MacConaillLevi A Garraway
Aug 26, 2010·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Natsumi IraharaShuji Ogino
Oct 19, 2010·Nucleic Acids Research·Simon A ForbesP Andrew Futreal
Feb 5, 2011·Blood·Nikhil C MunshiUNKNOWN International Myeloma Workshop Consensus Panel 2
Mar 25, 2011·Nature·Michael A ChapmanTodd R Golub
Jul 23, 2011·Genes & Cancer·Esther Castellano, Eugenio Santos
Jul 23, 2011·Genes & Cancer·Alberto Fernández-Medarde, Eugenio Santos
Sep 20, 2011·Seminars in Cell & Developmental Biology·Ian A Prior, John F Hancock
Oct 7, 2011·Journal of the National Comprehensive Cancer Network : JNCCN·Jill Corre, Hervé Avet-Loiseau
Apr 13, 2012·Nature Reviews. Cancer·Gareth J MorganFaith E Davies
Jul 10, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giulio MetroLucio Crinò
Dec 25, 2012·The Journal of Clinical Endocrinology and Metabolism·Nishant AgrawalDouglas W Ball
Apr 25, 2013·Cancer Discovery·Mindaugas AndrulisMarc S Raab

❮ Previous
Next ❯

Citations

Apr 8, 2014·Cytokine & Growth Factor Reviews·Jean-Baptiste Demoulin, Ahmed Essaghir
May 20, 2015·Current Opinion in Genetics & Development·Raphaël Szalat, Nikhil C Munshi
Oct 3, 2015·Leukemia & Lymphoma·Ellen Leich, Torsten Steinbrunn
Jul 3, 2015·EBioMedicine·Elizabeth O'DonnellNoopur Raje
Feb 29, 2016·Current Hematologic Malignancy Reports·Vijay Ramakrishnan, Anita D'Souza
Apr 18, 2015·European Journal of Haematology·Valeria SpinaDavide Rossi
Oct 10, 2014·British Journal of Haematology·Holger W Auner, Simone Cenci
Jan 13, 2015·British Journal of Haematology·Dean SmithKwee Yong
Feb 20, 2015·Hematology·Jesus San Miguel
Aug 8, 2014·BioMed Research International·Sanjay de MelWee-Joo Chng
Oct 28, 2016·British Journal of Haematology·Dean Smith, Kwee Yong
Aug 19, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian A WalkerGareth J Morgan
May 20, 2017·Expert Review of Molecular Diagnostics·Marta Lionetti, Antonino Neri
Aug 4, 2018·Annals of Hematology·Nicholas Burwick, Sanjai Sharma
Jan 27, 2018·Integrative Biology : Quantitative Biosciences From Nano to Macro·Joyce W KamandeSteven A Soper
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Raphael Szalat, Nikhil C Munshi
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Ajay K Nooka, Sagar Lonial
Dec 29, 2016·Proceedings of the National Academy of Sciences of the United States of America·Harmen van AndelSteven T Pals
Aug 5, 2020·Proceedings of the National Academy of Sciences of the United States of America·Fazal ShiraziRobert Z Orlowski
Nov 25, 2018·Annals of Hematology·Hartmut GoldschmidtLaurent Garderet
Sep 22, 2020·Briefings in Bioinformatics·Gunnar VölkelHans A Kestler
Nov 12, 2019·Frontiers in Oncology·Sergiu PascaHerman Einsele
Nov 30, 2019·Leukemia·Manisha BhutaniSaad Z Usmani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.